Файл: Название Стр.pdf

165
Вестник дерматологии и венерологии. 2015;(2):130–8.
293. Шуршалина, А. В. Клинико-морфологические особенности хронического эндометрита у женщин с нарушением репродуктивной функции: дис. …д-ра мед. наук: 14.01.01 /
Шуршалина Анна Владимировна. – М., 2007. – 280 с.
294. Шуршалина
АВ. Роль хронического эндометрита в развитии патологии репродуктивной функции. Российский медицинский журнал. 2007;(4):25–7.
295. Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod [Internet]. 2015;30(2):323–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385744 296. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil
Steril
[Internet].
2004;82(4):799–804.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15482749 297. Сухих Г, Шуршалина А. Хронический эндометрит. ГЭОТАР-Мед. Москва; 2010.
298. Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in
Turner’s syndrome: an analysis of the factors affecting the outcome. Hum Reprod [Internet].
1997;12(2):279–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9070711 299. Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben Rafael Z. Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update [Internet].
7(6):603–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11727869 300. Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr
Endocrinol
Rev
[Internet].
2012;9
Suppl
2:713–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22946282 301. SWYER GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J [Internet].
1955;2(4941):709–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13250193 302. Hagman A, Loft A, Wennerholm U-B, Pinborg A, Bergh C, Aittomäki K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study.
Hum
Reprod
[Internet].
2013;28(6):1598–609.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23539610 303. Practice Committee of American Society For Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil
Steril
[Internet].
2012;97(2):282–4.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22192347 304. Creatsas G, Deligeoroglou E, Tsimaris P, Pantos K, Kreatsa M. Successful pregnancy in a
Swyer syndrome patient with preexisting hypertension. Fertil Steril [Internet].
2011;96(2):e83--5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21782051 305. Morcel K, Camborieux L, Programme de Recherches sur les Aplasies Müllériennes, Guerrier
D. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. Orphanet J Rare Dis [Internet].
2007;2:13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17359527 306. MORRIS JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am J
Obstet
Gynecol
[Internet].
1953;65(6):1192–211.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/13057950 307. Committee on Adolescent Health Care. ACOG Committee Opinion No. 728: Müllerian
Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol [Internet].
2018;131(1):e35--e42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29266078 308. Raziel A, Friedler S, Gidoni Y, Ben Ami I, Strassburger D, Ron-El R. Surrogate in vitro

166 fertilization outcome in typical and atypical forms of Mayer-Rokitansky-Kuster-Hauser syndrome.
Hum
Reprod
[Internet].
2012;27(1):126–30.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22052385 309. Wood EG, Batzer FR, Corson SL. Ovarian response to gonadotrophins, optimal method for oocyte retrieval and pregnancy outcome in patients with vaginal agenesis. Hum Reprod
[Internet].
1999;14(5):1178–81.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10325257 310. Reichman DE, Laufer MR. Mayer-Rokitansky-Küster-Hauser syndrome: fertility counseling and treatment.
Fertil
Steril
[Internet].
2010;94(5):1941–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20172513 311. Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review.
Fertil
Steril
[Internet].
2009;91(5):1886–94.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18439594 312. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ.
Reproductive outcomes in women with congenital uterine anomalies: a systematic review.
Ultrasound
Obstet
Gynecol
[Internet].
2011;38(4):371–82.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21830244 313. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update [Internet].
7(2):161–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11284660 314. Letterie GS. Management of congenital uterine abnormalities. Reprod Biomed Online
[Internet].
2011;23(1):40–52.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21652266 315. Practice Committee of the American Society for Reproductive Medicine. Electronic address:
ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine.
Uterine septum: a guideline. Fertil Steril [Internet]. 2016;106(3):530–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27235766 316. Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis BC, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod
Biomed
Online
[Internet].
2014;29(6):665–83.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25444500 317. Dicker D, Ashkenazi J, Dekel A, Orvieto R, Feldberg D, Yeshaya A, et al. The value of hysteroscopic evaluation in patients with preclinical in-vitro fertilization abortions. Hum
Reprod
[Internet].
1996;11(4):730–1.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8671317 318. Lavergne N, Aristizabal J, Zarka V, Erny R, Hedon B. Uterine anomalies and in vitro fertilization: what are the results? Eur J Obstet Gynecol Reprod Biol [Internet]. 1996;68(1–
2):29–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8886677 319. Brucker S, Rall K, Campo R, Oppelt P, Isaacson K. Treatment of Congenital Malformations.
Semin Reprod Med. 2011 Mar;29(02):101–12.
320. Revel A. Defective endometrial receptivity. Fertil Steril [Internet]. 2012;97(5):1028–32.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22542142 321. Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS [Internet]. 2000;14(14):2093–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061649 322. Semprini AE, Macaluso M, Hollander L, Vucetich A, Duerr A, Mor G, et al. Safe conception

167 for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol [Internet]. 2013;208(5):402.e1--9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395921 323. Steenvoorden MMC, Cornelissen M, van Leeuwen E, Schuurman NM, Egberink HF,
Berkhout B, et al. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely. Fertil Steril [Internet]. 2012;98(1):173–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22584022 324. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril [Internet].
2004;81(6):1542–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15193474 325. Janssens RM, Lambalk CB, Schats R, Schoemaker J. Successful in-vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles: case report. Hum
Reprod
[Internet].
1999;14(10):2497–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10527976 326. Pelinck MJ, Hoek A, Simons AHM, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update [Internet]. 8(2):129–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12099628 327. Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod [Internet].
2001;16(2):259–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11157816 328. Lenton EA. Natural cycle IVF with and without terminal HCG: learning from failed cycles.
Reprod
Biomed
Online
[Internet].
2007;15(2):149–55.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697489 329. Kadoch I-J, Phillips SJ, Bissonnette F. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. Fertil Steril [Internet].
2011;96(5):1066–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036050 330. Ho JR, Paulson RJ. Modified natural cycle in in vitro fertilization. Fertil Steril [Internet].
2017;108(4):572–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965551 331. Shaulov T, Vélez MP, Buzaglo K, Phillips SJ, Kadoch IJ. Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience. J Assist Reprod
Genet
[Internet].
2015;32(7):1043–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26041679 332. Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, et al.
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin- releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum
Reprod
[Internet].
1999;14(3):683–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10221695 333. Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane database Syst Rev. 2013;(8):CD010550.
334. Kamath MS, Kirubakaran R, Mascarenhas M, Sunkara SK. Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis. Reprod Biomed
Online
[Internet].
2018;36(1):94–101.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29111312 335. Practice Committees of the American Society for Reproductive Medicine and the Society for
Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril
[Internet].
2013;99(3):663–6.
Available from:

168 http://www.ncbi.nlm.nih.gov/pubmed/23391409 336. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian R-C, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification.
Reprod
Biomed
Online
[Internet].
2010;21(4):566–71.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20822957 337. Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med [Internet].

2014;41(2):41–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25045627 338. Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”. Fertil
Steril
[Internet].
2010;94(2):496–501.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19589517 339. Tan S-L. [In vitro maturation: clinical and biological aspects]. J Gynecol Obstet Biol Reprod
(Paris)
[Internet].
2003;32(3
Pt
2):S52--6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12773921 340. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al.
Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online [Internet]. 2009;19(3):343–
51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778479 341. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod [Internet]. 2000;15(1):165–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10611207 342. Son W-Y, Chung J-T, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG- primed in vitro maturation cycles. Hum Reprod [Internet]. 2008;23(12):2680–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18775885 343. Elizur SE, Son W-Y, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril [Internet]. 2009;92(3):907–
12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18976750 344. Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol [Internet]. 2007;110(4):885–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17906024 345. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al.
Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012;27(12):3601–8.
346. Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013
May;99(6):1476–84.
347. Coyne K, Purdy M, Oâ€
TM
Leary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and
Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Front
Public
Heal
[Internet].
2014;2.
Available from: http://journal.frontiersin.org/article/10.3389/fpubh.2014.00246/abstract
348. Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin

169
(hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J
Assist
Reprod
Genet
[Internet].
2014;31(7):927–32.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24854484 349. Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril [Internet].
2012;97(5):1039–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22464086 350. Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ.
What exactly do we mean by “recurrent implantation failure”? A systematic review and opinion. Reprod Biomed Online [Internet]. 2014;28(4):409–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24581986 351. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online [Internet]. 2014;28(1):14–38.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24269084 352. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за
2013г. Проблемы репродукции. 2015;21(6):16–32.
353. Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за
2014г. Проблемы репродукции. 2016;22(5):8–21.
354. European IVF-Monitoring Consortium (EIM) for the European Society of Human
Reproduction and Embryology (ESHRE), Calhaz-Jorge C, de Geyter C, Kupka MS, de
Mouzon J, Erb K, et al. Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE. Hum Reprod. 2016;31(8):1638–52.
355. Bradshaw KD, Guzick DS, Grun B, Johnson N, Ackerman G. Cumulative pregnancy rates for donor insemination according to ovulatory function and tubal status. Fertil Steril
[Internet].
1987;48(6):1051–4.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/3678505 356. Hammond MG, Jordan S, Sloan CS. Factors affecting pregnancy rates in a donor insemination program using frozen semen. Am J Obstet Gynecol [Internet].
1986;155(3):480–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3752170 357. Chauhan M, Barratt CL, Cooke SM, Cooke ID. Differences in the fertility of donor insemination recipients--a study to provide prognostic guidelines as to its success and outcome.
Fertil
Steril
[Internet].
1989;51(5):815–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/2707456 358. ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update [Internet].
15(3):265–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19240042 359. Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review.
Hum
Reprod
[Internet].
2003;18(5):941–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12721166 360. Green KA, Zolton JR, Schermerhorn SM V, Lewis TD, Healy MW, Terry N, et al.
Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertil Steril [Internet]. 2017;107(4):924--
933.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28238492